Hot Features
Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease; and investigational diagnosti... Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease; and investigational diagnostic product candidate is called SavaDx, and it is a novel way to detect the presence of Alzheimer's disease from a small sample of blood, possibly years before the overt appearance of clinical symptoms. Mehr anzeigen
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -24.43 | -86.5391427559 | 28.23 | 33.98 | 3.7 | 19193255 | 8.95472246 | CS |
| 4 | -22.9 | -85.7677902622 | 26.7 | 33.98 | 3.7 | 6544141 | 11.75326316 | CS |
| 12 | -24.62 | -86.6291344124 | 28.42 | 33.98 | 3.7 | 3398810 | 17.25067154 | CS |
| 26 | -18.06 | -82.6166514181 | 21.86 | 42.2 | 3.7 | 3134850 | 18.59790343 | CS |
| 52 | -17.5 | -82.1596244131 | 21.3 | 42.2 | 3.7 | 2031644 | 19.73311463 | CS |
| 156 | -51.3 | -93.1034482759 | 55.1 | 62.49 | 3.7 | 1785116 | 27.08868929 | CS |
| 260 | 2.37 | 165.734265734 | 1.43 | 146.16 | 1.11 | 3095221 | 32.9576747 | CS |
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
